Perthes Disease in Norway
- Conditions
- Legg Calve Perthes Disease
- Registration Number
- NCT03885960
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
Calvé-Legg-Perthes disease (CLP) is a hip disease in children whose femoral head becomes completely or partially necrotic. The disease is most common in five-six years of age. The femoral head is gradually deformed during the active stages of the disease (5-7 years). By healing, the hip joint shape will vary from an approximately normal joint to pronounced changes, the hip joint will be irregular. Such a hip joint is available for osteoarthritis. The purpose of this study is to map the function of the hip, the patient's quality of life and especially the risk factors that affect the outcome of the previous CLP. A nationwide prospective study of CLP was conducted between 1996 and 2000. All children with newly diagnosed Perthes disease (425) were registered. The current study will follow up all these patients with an average follow-up of 20 years. Radiological endpoints are evidence of hip osteoarthritis. Patient-reported outcomes (PROMS) should illuminate the function of the hip and quality of life.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 216
Not provided
- Death upon follow up
- Other skeletal dysplasia
- Patient not able to give consent,
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hip osteoarthritis an average of 20 years follow-up radiographic measurement of weight bearing zone
Hip function an average of 20 years follow-up PROMS HOOS
- Secondary Outcome Measures
Name Time Method Hip ROM an average of 20 years follow-up functional test of range of motion of the hip
Gluteal muscle strength an average of 20 years follow-up Trendelenburg test
Hip strength an average of 20 years follow-up single leg hop test - 6 meters
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Oslo University Hospital - Rikshospitalet
🇳🇴Oslo, Sognsvannsveien 20, Norway